As manufacturers increasingly use closed, gloveless isolators for aseptic processing of new sterile injectable drug products, they are dealing with contradictory feedback from regulatory authorities.
Michael Schneider, the global head of technical innovation drug product at Roche Holding AG/Genentech, described the benefits of robotic aseptic filling using closed gloveless isolators at an International Forum...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?